MDC Connects - Complex Medicines: Selection and Characterisation of the Lead

  • 14:00, 18 May 21 - 15:00, 18 May 21
  • Medicines Discovery Catapult, Macclesfield
  • Print page
The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs.

This webinar will look at assays, technologies and capabilities which can be employed to characterise the lead molecule.

AGENDA

- Developing the assay cascade for complex medicines - Tilly Bingham (Concept Life Sciences)
- CryoEM in characterisation and quality control of complex medicines - Rebecca Thompson (Astbury Biostructure Laboratory)
- Cellular internalisation and trafficking of complex medicines - James Szczerkowski, Postdoc Scientist - Advanced Microscopy (MDC)

Register